Abstract
Over the past 20 years, the fields of biomaterial sciences and tissue engineering have evolved into new clinically relevant applications including regenerative medicine and cell based therapies. Tissue engineering therapies are based on different types of materials and scaffolds combined with cells and submitted to engineering processes in order to create bio-scaffolds which will improve or replace biological functions. Despite the effort, only a few therapies, such as bone, cartilage and nerve, succeeded in clinical applications. Furthermore, the major drawback in standard application of these therapies was the critical size defects which could be covered with engineered materials, as well as inability to provide sustainable vascular supply to the created bio-scaffolds. In 1998, the first successful hand transplantation was performed in France, and the field of vascularized composite allotransplantation (VCA) was introduced into the armamentarium of reconstructive surgery (Dubernard in Am J Transplant 5(6):1580–1, 2005; Petruzzo et al. in Am J Transplant 6(7):1718–24, 2006; Lanzetta et al. in Transplantation 79(9):1210–4, 2005). As a result, a new generation of transplants including hand, face, larynx abdominal wall, lower extremities and penile transplantation became available to patients who had lost these unique organs and were previously unable to achieve restored function using standard reconstructive procedures. Ethical debate on the need for life-long immunosuppressive therapy to prevent rejection of the VCA overshadowed the success of face and hand transplants. Thus, a new, challenging opportunity developed to combine approaches of tissue engineering and regenerative medicine and ultimately restore the framework, function, aesthetics and survival of the VSA transplants. This overview presents the unique opportunities of merging established and new technologies into the burgeoning field of reconstructive transplantation.
Similar content being viewed by others
References
Dubernard J. Composite tissue allografts: a challenge for transplantologists. Am J Transplant. 2005;5(6):1580–1.
Petruzzo P, Badet L, Gazarian A, et al. Bilateral hand transplantation: six years after the first case. Am J Transplant. 2006;6(7):1718–24.
Lanzetta M, Petruzzo P, Margreiter R, et al. The international registry on hand and composite tissue transplantation. Transplantation. 2005;79(9):1210–4.
Siemionow M, Papay F, Alam D, et al. Near-total human face transplantation for a severely disfigured patient in the USA. Lancet. 2009;374:203.
Siemionow M, Gozel-Ulusal B, Engin Ulusal A, et al. Functional tolerance following face transplantation in the rat. Transplantation. 2003;75:1067.
Siemionow M, Unal S, Agaoglu G, et al. A cadaver study in preparation for facial allograft transplantation in humans: part I: what are alternative sources for total facial defect coverage? Plast Reconstr Surg. 2006;117(864):873.
Siemionow M, Klimczak A. Advances in the development of experimental composite tissue transplantation models. Transplant Int. 2010;23:2.
Siemionow M, Agaoglu G, Unal S. A cadaver study in preparation for facial allograft transplantation in humans: part II: mock facial transplantation. Plast Reconstr Surg. 2006;117(876):886.
Siemionow M, Papay F, Djohan R, et al. First U.S. near-total human face transplantation-a paradigm shift for massive complex injuries. Plast Reconstr Surg. 2010;125:111.
Birchall M, Lorenz R, Berke G, et al. Laryngeal transplantation in 2005: a review. Am J Transplant. 2006;6(1):20–6.
Mansbridge J. Skin tissue engineering. J Biomater Sci Polym Ed. 2008;19(8):955–68.
Stern-Straeter J, Riedel F, Bran G, et al. Advances in skeletal muscle tissue engineering. In Vivo. 2007;21(3):435–44.
Roberts S, Howard D, Buttery L, Shakesheff K. Clinical applications of musculoskeletal tissue engineering. Br Med Bull. 2008;86:7–22. doi:10.1093/bmb/ldn016.
Howard D, Buttery L, Shakesheff K, Roberts S. Tissue engineering: strategies, stem cells and scaffolds. J Anat. 2008;213(1):66–72. doi:10.1111/j.1469-7580.2008.00878.x.
Healy K, Guldberg R. Bone tissue engineering. J Musculoskelet Neuronal Interact. 2007;7(4):328–30.
Gu X, Ding F, Williams D. Neural tissue engineering options for peripheral nerve regeneration. Biomaterials. 2014;35(24):6143–56. doi:10.1016/j.biomaterials.
Shearn J, Kinneberg K, Dyment N, et al. Tendon tissue engineering: progress, challenges, and translation to the clinic. J Musculoskelet Neuronal Interact. 2011;11(2):163–73.
Nemeno-Guanzon G, Soojung Lee S, Berg J, et al. Trends in tissue engineering for blood vessels. J Biomed Biotechnol. 2012;2012:1–14. doi:10.1155/2012/956345.
Do A, Khorsand B, Geary S, Salem A. 3D printing of scaffolds for tissue regeneration applications. Adv Healthc Mater. 2015;. doi:10.1002/adhm.201500168.
Conde M, Chisini L, Demarco F, Nör J, Casagrande L, Tarquinio S. Stem cell-based pulp tissue engineering: variables enrolled in translation from the bench to the bedside, a systematic review of literature. Int Endod J. 2015;. doi:10.1111/iej.12489.
Michel J, Penna M, Kochen J, Cheung H. Recent advances in hydroxyapatite scaffolds containing mesenchymal stem cells. Stem Cells Int. 2015;2015:305217. doi:10.1155/2015/305217.
Gonfiotti A, Jaus MO, Barale D, et al. The first tissue-engineered airway transplantation: 5-year follow-up results. Lancet. 2014;383(9913):238–44. doi:10.1016/S0140-6736(13)62033-4.
Gugatschka M, Ohno S, Saxena A, Hirano S. Regenerative medicine of the larynx. Where are we today? A review. J Voice. 2012;26(5):670.e7-13. doi:10.1016/j.jvoice.2012.03.009.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Siemionow, M. Vascularized composite allotransplantation: a new concept in musculoskeletal regeneration. J Mater Sci: Mater Med 26, 266 (2015). https://doi.org/10.1007/s10856-015-5601-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10856-015-5601-5